March 20, 2001--MDS Proteomics Inc., a global biotechnology company focused on functional proteomics, today announced that it has opened a new facility in Odense, Denmark to house protein discovery factories that seamlessly integrate biology, high performance supercomputing and molecular analysis for the design and development of new medicines. The company is also expanding its Toronto, Canada headquarters and facilities are in development in Boston, MA and Charlottesville, NC.
The new Denmark facility is a major center of expertise for MDS Proteomics scientists to enhance the understanding of how proteins function at a cellular level. More than 60 scientists occupy the 30,000 sq. ft. building, which houses a large number of highly customized mass spectrometers and the 11th largest Linux cluster in the world, consisting of 101 computers, each with 2 x 1Ghz CPU & 2 GB ram.
``The expansion of our Denmark and North American presence is additional proof that we are well-positioned to anticipate and meet the growing market opportunity in the field of proteomics,'' said Frank Gleeson, president and chief executive officer, MDS Proteomics. ``MDS Proteomics recognizes that by increasing our geographic footprint, we can continue to attract the most talented scientists located in major biotechnology centers worldwide. In Odense, we are building on the extensive expertise and international reputation of Matthias Mann and Ole Vorm.''
MDS Proteomics is currently expanding its Toronto presence with a 50,000 sq. ft., state-of-the-art facility for analyzing protein interaction pathways, producing data for its proprietary BIND database to select and validate targets for its partners. Informatics research will be conducted in Toronto, using the world's leading supercomputing infrastructure, built in collaboration with IBM.
Scientists working in the soon-to-be opened Boston facility will focus on high throughput screening, structural biology and drug design, medicinal chemistry and protein identification. This location also establishes a geographic closeness to Partners Healthcare, which has collaborated with MDS Proteomics to gain a deeper understanding of how to utilize the study of protein-to-protein pathways to improve patient care.
Lastly, MDS Proteomics' Charlottesville facility, located in close proximity to the University of Virginia, will specialize in the analysis of complex mixtures of proteins to identify novel membrane bound receptor proteins as targets for therapeutic drugs.... |
